Chapter 22 - The Eighteen Percent Moves

The Drake Pelagic shareholder meeting took place under armed security in New York six weeks later.
Nysara did not attend.
She had no interest in watching men argue over a company built from Sorelle’s pain.
Gabriel attended because the Blue Veil Trust asked him to testify about the auction and Eva’s insurance records. Daniel attended because he had waived confidentiality and agreed to answer questions under oath.
Octavien attended by video from federal detention.
He still controlled enough voting power to make the meeting dangerous.
Until the eighteen percent moved.
The transfer did not happen theatrically. There was no gavel, no gasp, no dramatic seizure of certificates.
A Delaware Chancery Court order arrived by secure electronic filing at 10:17 a.m., enforcing the escrow mechanism provisionally after finding overwhelming evidence that Drake interests had materially violated the conservation easement and concealed those violations from lenders.
The pledged founder voting block transferred into court-supervised control for the Blue Veil Trust pending final accounting.
For several seconds, nobody spoke. Then phones began vibrating around the table as lenders, analysts, and outside counsel saw the filing. One director who had spent the morning defending Octavien quietly closed the leather folder bearing the old chairman’s crest and moved it aside. Gabriel noticed the gesture because it was so small. Empires often announced themselves with architecture and ceremony; their endings could look like a folder being moved six inches.
Octavien’s voting control collapsed.
Three independent directors immediately moved to remove him as chairman and chief executive.
The motion passed.
On the conference screen, Octavien did not blink.
Gabriel watched the board secretary read the tally.
Years of control ended in less than thirty seconds.
But the important decision came next.
The board voted to terminate Blue Meridian, surrender pending extraction permits, fund environmental remediation, and enter mediation over historical Pelagene royalties.
One director objected.
A representative from a hospital purchasing coalition had been invited to observe. She answered before Marisol could. “Hospitals are not asking you to destroy Pelagene. We are asking whether patients should depend on a supplier whose management can hide a material chain-of-title dispute for decades. Reliability includes governance.”
The director frowned. “This company cannot survive if every successful patent becomes a moral referendum on research conducted thirty years ago.”
Marisol Kent, representing Blue Veil, answered from across the table.
“This is not a referendum. Your founder signed a contract. Your former management hid it. You borrowed billions after certifying it did not exist. Morality is not the only problem you have.”
The room went quiet.
Money, again, made humans hear.
By afternoon, a framework agreement took shape.
Drake Pelagic would pay $212 million into Blue Veil over ten years, reflecting unpaid royalties, interest, and remediation contributions subject to final audit. The agreement also required the company to finance removal of dormant Calder hardware, surrender undisclosed biological archives to an independent custodian, and waive any claim that future sightings of Valeths created commercial research rights. No money would go personally to Nysara. The trust would fund protected monitoring, anti-poaching enforcement, habitat preservation, and independent oversight of research in the Meridian Shelf region.
Pelagene would remain available to hospitals.
That mattered to Nysara.
When Gabriel had asked whether she wanted the patents destroyed, she had looked confused.
“Medicine helps sick humans?”
“Yes.”
“Then do not make sick humans pay for Octavien.”
Instead, future licensing profits would include a permanent contribution to Blue Veil, and public patent histories would acknowledge the unethical origin of the source material.
Not clean.
Nothing could make it clean.
But no one would again pretend the medicine had come from nowhere.
During a break, Daniel stood beside Gabriel at a window overlooking lower Manhattan.
“You know,” Daniel said, “your sister would hate this room.”
Gabriel almost smiled. “She hated every room where men said synergy.”
Daniel laughed once, then grew serious.
“I keep thinking about the settlement.”
“The three-point-two million?”
“Yes.”
“You should.”
Daniel nodded.
Gabriel looked at him.
“I am not going to tell you it’s forgiven.”
“I know.”
“I also don’t want to spend the rest of my life punishing you instead of missing her.”
Daniel’s eyes lowered.
“That is more mercy than I deserve.”
“Maybe. Don’t make it about deserving.”
They stood in silence.
Across the room, lawyers circulated revised language.
The Blue Veil Trust would remain controlled by human trustees because that was what existing law understood. But the new charter created a protected advisory role for Nysara and any other Valeth representatives who voluntarily came forward. No biological verification could be demanded as a condition of participation.
Nysara had insisted on that clause.
“No more prove body to prove voice,” she said.
At 4:03 p.m., the framework was signed.
Gabriel called her afterward.
“The project is dead.”
“Blue Meridian?”
“Yes.”
“No digging near Veil?”
“No digging.”
Nysara was quiet.
Then she asked, “Octavien loses company?”
“He already did.”
“Good.”
Gabriel laughed.
Nysara did not.
“He made company his tank,” she said. “Now door opened.”
Gabriel looked back through the glass wall of the boardroom.
May you like
Directors who had once treated Octavien’s authority as permanent were gathering his nameplates from the table.
For once, Nysara’s metaphor was exact.